Nomura Holdings Inc. grew its holdings in Axon Enterprise, Inc. (NASDAQ:AXON – Free Report) by 0.2% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 75,024 shares of the biotechnology company’s stock after acquiring an additional 142 shares during the quarter. Nomura Holdings Inc. owned 0.10% of Axon Enterprise worth $19,381,000 as of its most recent filing with the Securities and Exchange Commission.
Several other hedge funds and other institutional investors have also modified their holdings of the stock. Pathstone Family Office LLC boosted its holdings in Axon Enterprise by 53.1% during the third quarter. Pathstone Family Office LLC now owns 2,415 shares of the biotechnology company’s stock valued at $481,000 after purchasing an additional 838 shares in the last quarter. Deutsche Bank AG grew its position in Axon Enterprise by 13.3% in the third quarter. Deutsche Bank AG now owns 193,125 shares of the biotechnology company’s stock valued at $38,430,000 after acquiring an additional 22,694 shares during the period. Rhumbline Advisers raised its stake in Axon Enterprise by 2.5% during the third quarter. Rhumbline Advisers now owns 149,207 shares of the biotechnology company’s stock worth $29,691,000 after acquiring an additional 3,615 shares in the last quarter. Aviva PLC lifted its holdings in shares of Axon Enterprise by 1.0% during the third quarter. Aviva PLC now owns 114,975 shares of the biotechnology company’s stock valued at $22,879,000 after acquiring an additional 1,093 shares during the period. Finally, Prudential PLC boosted its stake in shares of Axon Enterprise by 328.1% in the 3rd quarter. Prudential PLC now owns 11,786 shares of the biotechnology company’s stock valued at $2,345,000 after purchasing an additional 9,033 shares in the last quarter. Institutional investors and hedge funds own 79.08% of the company’s stock.
Insider Activity at Axon Enterprise
In related news, President Joshua Isner sold 44,000 shares of the business’s stock in a transaction on Thursday, May 9th. The stock was sold at an average price of $309.96, for a total transaction of $13,638,240.00. Following the sale, the president now owns 275,843 shares in the company, valued at approximately $85,500,296.28. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. In related news, Director Jeri Williams sold 308 shares of Axon Enterprise stock in a transaction that occurred on Thursday, May 9th. The stock was sold at an average price of $310.07, for a total value of $95,501.56. Following the transaction, the director now directly owns 1,607 shares of the company’s stock, valued at $498,282.49. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, President Joshua Isner sold 44,000 shares of the firm’s stock in a transaction that occurred on Thursday, May 9th. The stock was sold at an average price of $309.96, for a total transaction of $13,638,240.00. Following the transaction, the president now owns 275,843 shares of the company’s stock, valued at approximately $85,500,296.28. The disclosure for this sale can be found here. Insiders have sold 89,447 shares of company stock valued at $27,684,677 over the last ninety days. 5.70% of the stock is owned by corporate insiders.
Wall Street Analysts Forecast Growth
Check Out Our Latest Report on AXON
Axon Enterprise Stock Performance
Shares of NASDAQ:AXON traded up $1.37 on Tuesday, hitting $298.54. The company had a trading volume of 45,208 shares, compared to its average volume of 486,877. The stock has a 50 day moving average price of $297.59 and a 200 day moving average price of $281.67. The company has a current ratio of 2.91, a quick ratio of 2.55 and a debt-to-equity ratio of 0.37. The stock has a market cap of $22.53 billion, a price-to-earnings ratio of 86.89 and a beta of 0.91. Axon Enterprise, Inc. has a 1-year low of $175.37 and a 1-year high of $329.87.
Axon Enterprise (NASDAQ:AXON – Get Free Report) last announced its earnings results on Friday, May 10th. The biotechnology company reported $1.15 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.95 by $0.20. The company had revenue of $460.74 million during the quarter, compared to analysts’ expectations of $441.57 million. Axon Enterprise had a net margin of 15.60% and a return on equity of 11.71%. Axon Enterprise’s quarterly revenue was up 34.3% on a year-over-year basis. During the same quarter in the previous year, the business posted $0.51 earnings per share. Analysts expect that Axon Enterprise, Inc. will post 2.35 EPS for the current year.
About Axon Enterprise
Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.
Read More
- Five stocks we like better than Axon Enterprise
- What is the Dogs of the Dow Strategy? Overview and Examples
- Super Micro AI Stock: Should You Invest After a 275% Increase?
- How to Use the MarketBeat Dividend Calculator
- VinFast Auto’s EV Sales Target: Stock Market Hype or Reality?
- The How and Why of Investing in Gold Stocks
- Beyond Meat Forecast: Is There Any Hope Left for This Stock?
Want to see what other hedge funds are holding AXON? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Axon Enterprise, Inc. (NASDAQ:AXON – Free Report).
Receive News & Ratings for Axon Enterprise Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Axon Enterprise and related companies with MarketBeat.com's FREE daily email newsletter.